325 related articles for article (PubMed ID: 34541602)
1. Identification of potential genes related to breast cancer brain metastasis in breast cancer patients.
Zhang L; Wang L; Yang H; Li C; Fang C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34541602
[TBL] [Abstract][Full Text] [Related]
2. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
[TBL] [Abstract][Full Text] [Related]
3. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
Tang D; Zhao X; Zhang L; Wang Z; Wang C
J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
[TBL] [Abstract][Full Text] [Related]
4. Identification of Key Genes Associated with Brain Metastasis from Breast Cancer: A Bioinformatics Analysis.
Zeng C; Lin M; Jin Y; Zhang J
Med Sci Monit; 2022 Mar; 28():e935071. PubMed ID: 35296631
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
An M; Zang X; Wang J; Kang J; Tan X; Fu B
Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
[TBL] [Abstract][Full Text] [Related]
6. Identifying the mRNAs associated with Bladder cancer recurrence.
Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
[TBL] [Abstract][Full Text] [Related]
7. Identification of Driver Genes and Interaction Networks Related to Brain Metastasis in Breast Cancer Patients.
Zhang H; Wang X; Hou C; Yang Z
Dis Markers; 2022; 2022():7631456. PubMed ID: 35132338
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis Identifies COL1A1, COL3A1, and POSTN as Key Genes Associated with Brain Metastasis in Patients with Breast Cancer.
Wu W; Zheng L
Evid Based Complement Alternat Med; 2022; 2022():7812218. PubMed ID: 35990840
[TBL] [Abstract][Full Text] [Related]
11. Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods.
Yang Z; Sun R; Qu G; Wang F; Yin Z; Zhang T; Wang P; Li S; Lin S
Transl Cancer Res; 2023 May; 12(5):1112-1127. PubMed ID: 37304544
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract][Full Text] [Related]
13. A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival.
Giannoudis A; Clarke K; Zakaria R; Varešlija D; Farahani M; Rainbow L; Platt-Higgins A; Ruthven S; Brougham KA; Rudland PS; Jenkinson MD; Young LS; Falciani F; Palmieri C
Sci Rep; 2019 Dec; 9(1):18518. PubMed ID: 31811234
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
15. Identification of genes and pathways related to breast cancer metastasis in an integrated cohort.
Wang L; Mo C; Wang L; Cheng M
Eur J Clin Invest; 2021 Jul; 51(7):e13525. PubMed ID: 33615456
[TBL] [Abstract][Full Text] [Related]
16. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Profiling of Breast Cancer Brain Metastasis.
Lee JY; Park K; Lee E; Ahn T; Jung HH; Lim SH; Hong M; Do IG; Cho EY; Kim DH; Kim JY; Ahn JS; Im YH; Park YH
Sci Rep; 2016 Jun; 6():28623. PubMed ID: 27340107
[TBL] [Abstract][Full Text] [Related]
19. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
Ren H; Hu D; Mao Y; Su X
Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
